Metabolite analysis distinguishes between mice with epidermolysis bullosa acquisita and healthy mice

Orphanet Journal of Rare Diseases

Volumn 8, Issue 1, 2013, Pages

  Schönig, Sarah ^a,b   Recke, Andreas ^a,b   Hirose, Misa ^a,b   Ludwig, Ralf J ^a,b   Seeger, Karsten ^a,b  

^a Excellence Cluster Inflammation at Interfaces ^*  (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

Author keywords

1H NMR; Epidermolysis bullosa acquisita; Metabolism; Type VII collagen

Indexed keywords

AMINO ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; ENERGY BALANCE; ENERGY CONSUMPTION; EPIDERMOLYSIS BULLOSA ACQUISITA; FILTRATION; METABOLITE; METABOLOMICS; MOUSE; NONHUMAN; PARTIAL LEAST SQUARES REGRESSION; PRINCIPAL COMPONENT ANALYSIS; PROTON NUCLEAR MAGNETIC RESONANCE; RANDOM FOREST;

ANIMALS; AUTOANTIBODIES; BLOOD GLUCOSE; COLLAGEN TYPE VII; DERMIS; EPIDERMIS; EPIDERMOLYSIS BULLOSA ACQUISITA; HUMANS; ISOLEUCINE; LACTOSE; MAGNETIC RESONANCE SPECTROSCOPY; METABOLOMICS; MICE; PROLINE; SKIN;

EID: 84879427784     PISSN: None     EISSN: 17501172     Source Type: Journal    
DOI: 10.1186/1750-1172-8-93     Document Type: Article

References (46)

1. Epidermolysis bullosa acquisita: what's new? Ishii N, Hamada T, Dainichi T, Karashima T, Nakama T, Yasumoto S, Zillikens D, Hashimoto T, J Dermatol 2010 37 220 230 10.1111/j.1346-8138.2009.00799.x 20507385
2. Two cases of epidermolysis bullosa. Elliott GT, J Cutan Genitourin Dis 1895 13 10
3. Epidermolysis bullosa acquisita. Report of three cases and review of all published cases. Roenigk HH Jr, Ryan JG, Bergfeld WF, Arch Dermatol 1971 103 1 10 10.1001/archderm.1971.04000130003001 4321800
4. Epidermolysis bullosa acquisita antigen is the globular carboxyl terminus of type VII procollagen. Woodley DT, Burgeson RE, Lunstrum G, Bruckner-Tuderman L, Reese MJ, Briggaman RA, J Clin Invest 1988 81 683 687 10.1172/JCI113373 3278005 (Pubitemid 18079715)
5. Epidermolysis bullosa acquisita: autoimmunity to anchoring fibril collagen. Chen M, Kim GH, Prakash L, Woodley DT, Autoimmunity 2012 45 91 101 10.3109/08916934.2011.606450 21955050
6. Pathogenesis of epidermolysis bullosa acquisita. Ludwig RJ, Zillikens D, Dermatol Clin 2011 29 493 501 10.1016/j.det.2011.03.003 21605817
7. Identification of quantitative trait loci in experimental epidermolysis bullosa acquisita. Ludwig RJ, Müller S, Marques A, Recke A, Schmidt E, Zillikens D, Möller S, Ibrahim SM, J Invest Dermatol 2012 132 1409 1415 10.1038/jid.2011.466 22297639
8. Genetic identification and functional validation of FcγRIV as key molecule in autoantibody-induced tissue injury. Kasperkiewicz M, Nimmerjahn F, Wende S, Hirose M, Iwata H, Jonkman MF, Samavedam U, Gupta Y, Möller S, Rentz E, et al. J Pathol 2012 228 8 19 22430937
9. Heat-shock protein 90 inhibition in autoimmunity to type VII collagen: evidence that nonmalignant plasma cells are not therapeutic targets. Kasperkiewicz M, Müller R, Manz R, Magens M, Hammers CM, Somlai C, Westermann J, Schmidt E, Zillikens D, Ludwig RJ, Orosz A, Blood 2011 117 6135 6142 10.1182/blood-2010-10-314609 21490339
10. PI3Kβ plays a critical role in neutrophil activation by immune complexes. Kulkarni S, Sitaru C, Jakus Z, Anderson KE, Damoulakis G, Davidson K, Hirose M, Juss J, Oxley D, Chessa TA, et al. Sci Signal 2011 4 a23 10.1126/scisignal.2001617 21487106
11. Metabonomics technologies and their applications in physiological monitoring, drug safety assessment and disease diagnosis. Lindon JC, Holmes E, Bollard ME, Stanley EG, Nicholson JK, Biomarkers 2004 9 1 31 10.1080/13547500410001668379 15204308 (Pubitemid 38660013)
12. Metabonomics: a platform for studying drug toxicity and gene function. Nicholson JK, Connelly J, Lindon JC, Holmes E, Nat Rev Drug Discov 2002 1 153 161 10.1038/nrd728 12120097 (Pubitemid 41646523)
13. Metabolic changes in autoimmune diseases. Seeger K, Curr Drug Discov Technol 2009 6 256 261 10.2174/157016309789869074 20025593
14. Metabolism of the colonic mucosa in patients with inflammatory bowel diseases: an in vitro proton magnetic resonance spectroscopy study. Balasubramanian K, Kumar S, Singh RR, Sharma U, Ahuja V, Makharia GK, NR J, Magn Reson Imaging 2009 27 79 86 10.1016/j.mri.2008.05.014 18599242
15. Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. Marchesi JR, Holmes E, Khan F, Kochhar S, Scanlan P, Shanahan F, Wilson ID, Wang Y, J Proteome Res 2007 6 546 551 10.1021/pr060470d 17269711 (Pubitemid 46340158)
16. Nontargeted urinary metabolite profiling of a mouse model of Crohn's disease. Lin HM, Edmunds SI, Helsby NA, Ferguson LR, Rowan DD, J Proteome Res 2009 8 2045 2057 10.1021/pr800999t 19275240
17. Metabolic assessment of gradual development of moderate experimental colitis in IL-10 deficient mice. Martin FP, Rezzi S, Philippe D, Tornier L, Messlik A, Hölzlwimmer G, Baur P, Quintanilla-Fend L, Loh G, Blaut M, et al. J Proteome Res 2009 8 2376 2387 10.1021/pr801006e 19323467
18. 1H NMR spectroscopy. Weljie AM, Dowlatabadi R, Miller BJ, Vogel HJ, Jirik FR, J Proteome Res 2007 6 3456 3464 10.1021/pr070123j 17696462 (Pubitemid 47522736)
19. 1H NMR spectroscopy-based interventional metabolic phenotyping: a cohort study of rheumatoid arthritis patients. Lauridsen MB, Bliddal H, Christensen R, Danneskiold-Samsøe B, Bennett R, Keun H, Lindon JC, Nicholson JK, Dorff MH, Jaroszewski JW, et al. J Proteome Res 2010 9 4545 4553 10.1021/pr1002774 20701312
20. Detection of autosomal dominant polycystic kidney disease by NMR spectroscopic fingerprinting of urine. Gronwald W, Klein MS, Zeltner R, Schulze BD, Reinhold SW, Deutschmann M, Immervoll AK, Böger CA, Banas B, Eckardt KU, Oefner PJ, Kidney Int 2011 79 1244 1253 10.1038/ki.2011.30 21389975
21. 1H NMR-based metabonomic analysis of metabolic changes in streptozotocin-induced diabetic rats. Zhao L, Liu X, Xie L, Gao H, Lin D, Anal Sci 2010 26 1277 1282 10.2116/analsci.26.1277 21157097
22. 1H-NMR-based metabolomics. Serkova NJ, Niemann CU, Expert Rev Mol Diagn 2006 6 717 731 10.1586/14737159.6.5.717 17009906 (Pubitemid 44525597)
23. Dynamic metabolomic data analysis: a tutorial review. Smilde AK, Westerhuis JA, Hoefsloot HC, Bijlsma S, Rubingh CM, Vis DJ, Jellema RH, Pijl H, Roelfsema F, van der Greef J, Metabolomics 2010 6 3 17 10.1007/s11306-009-0191-1 20339444
24. Chemometrics in metabolomics-a review in human disease diagnosis. Madsen R, Lundstedt T, Trygg J, Anal Chim Acta 2010 659 23 33 10.1016/j.aca.2009.11.042 20103103
25. A search for biomarkers as diagnostic tools for food allergy: a pilot study in peanut-allergic patients. Peeters KA, Lamers RJ, Penninks AH, Knol EF, Bruijnzeel-Koomen CA, van Nesselrooij JH, Knulst AC, Int Arch Allergy Immunol 2011 155 23 30 10.1159/000318654 21109745
26. Serum metabolomics reveals higher levels of polyunsaturated fatty acids in lepromatous leprosy: potential markers for susceptibility and pathogenesis. Al-Mubarak R, Vander Heiden J, Broeckling CD, Balagon M, Brennan PJ, Vissa VD, PLoS Negl Trop Dis 2011 5 1303 10.1371/journal.pntd.0001303 21909445
27. 1H NMR-based metabolomic study of metabolic profiling for systemic lupus erythematosus. Ouyang X, Dai Y, Wen JL, Wang LX, Lupus 2011 20 1411 1420 10.1177/0961203311418707 21976403
28. Clearance rates of circulating and tissue-bound autoantibodies to type VII collagen in experimental epidermolysis bullosa acquisita. Kasperkiewicz M, Hirose M, Recke A, Schmidt E, Zillikens D, Ludwig RJ, Br J Dermatol 2010 162 1064 1070 10.1111/j.1365-2133.2010.09680.x 20222918
29. Metabolic changes during cellular senescence investigated by proton NMR-spectroscopy. Gey C, Seeger K, Mech Ageing Dev 2013 134 130 138 10.1016/j.mad.2013.02.002 23416267
30. Generation of antibodies of distinct subclasses and specificity is linked to H2s in an active mouse model of epidermolysis bullosa acquisita. Ludwig RJ, Recke A, Bieber K, Müller S, Marques Ade C, Banczyk D, Hirose M, Kasperkiewicz M, Ishii N, Schmidt E, et al. J Invest Dermatol 2011 131 167 176 10.1038/jid.2010.248 20720563
31. Complement-fixing anti-type VII collagen antibodies are induced in Th1-polarized lymph nodes of epidermolysis bullosa acquisita-susceptible mice. Hammers CM, Bieber K, Kalies K, Banczyk D, Ellebrecht CT, Ibrahim SM, Zillikens D, Ludwig RJ, Westermann J, J Immunol 2011 187 5043 5050 10.4049/jimmunol. 1100796 21967893
32. 1H NMR fingerprints. Hochrein J, Klein MS, Zacharias HU, Li J, Wijffels G, Schirra HJ, Spang R, Oefner PJ, Gronwald W, J Proteome Res 2012 11 6242 6251 23116257
33. Tackling the widespread and critical impact of batch effects in high-throughput data. Leek JT, Scharpf RB, Bravo HC, Simcha D, Langmead B, Johnson WE, Geman D, Baggerly K, Irizarry RA, Nat Rev Genet 2010 11 733 739 20838408
34. Modified Jack-knife estimation of parameter uncertainty in bilinear modelling by partial least squares regression (PLSR). Martens H, Martens M, Food Quality and Preference 2000 11 5 16 10.1016/S0950-3293(99)00039-7
35. Metabolic assessment of gradual development of moderate experimental colitis in IL-10 deficient mice. Martin F-PJ, Rezzi S, Montoliu I, Philippe D, Tornier L, Messlik A, Hölzlwimmer G, Baur P, Quintanilla-Fend L, Loh G, et al. J Proteome Res 2009 8 2376 2387 10.1021/pr801006e 19323467
36. The epidermolysis bullosa acquisita antigen (type VII collagen) is present in human colon and patients with Crohn's disease have autoantibodies to type VII collagen. Chen M, O'Toole EA, Sanghavi J, Mahmud N, Kelleher D, Weir D, Fairley JA, Woodley DT, J Invest Dermatol 2002 118 1059 1064 10.1046/j.1523-1747.2002.01772.x 12060403 (Pubitemid 34639186)
37. Autoantibody-induced intestinal inflammation and weight loss in experimental epidermolysis bullosa acquisita. Ishii N, Recke A, Mihai S, Hirose M, Hashimoto T, Zillikens D, Ludwig RJ, J Pathol 2011 224 234 244 10.1002/path.2857 21381035
38. Glutamine. Labow BI, Souba WW, World J Surg 2000 24 1503 1513 10.1007/s002680010269 11193715 (Pubitemid 32047279)
39. The covalent structure of collagen. Amino-acid sequence of peptide 1-CB6-C2. Fietzek PP, Rexrodt FW, Wendt P, Stark M, Kühn K, Eur J Biochem 1972 30 163 168 10.1111/j.1432-1033.1972.tb02083.x 4343807
40. The distribution of α6β4 integrins in lesional and non-lesional skin in bullous pemphigoid. Venning VA, Allen J, Aplin JD, Kirtschig G, Wojnarowska F, Br J Dermatol 1992 127 103 111 10.1111/j.1365-2133. 1992.tb08040.x 1390136
41. Immunofluorescence in dermatology. Mutasim DF, Adams BB, J Am Acad Dermatol 2001 45 803 824 10.1067/mjd.2001.117518 11712024 (Pubitemid 33096618)
42. DNA methylation of colon mucosa in ulcerative colitis patients: correlation with inflammatory status. Saito S, Kato J, Hiraoka S, Horii J, Suzuki H, Higashi R, Kaji E, Kondo Y, Yamamoto K, Inflamm Bowel Dis 2011 17 1955 1965 10.1002/ibd.21573 21830274
43. An endogenously anti-inflammatory role for methylation in mucosal inflammation identified through metabolite profiling. Kominsky DJ, Keely S, MacManus CF, Glover LE, Scully M, Collins CB, Bowers BE, Campbell EL, Colgan SP, J Immunol 2011 186 6505 6514 10.4049/jimmunol.1002805 21515785
44. Increased blood phenylalanine to tyrosine ratio in HIV-1 infection and correction following effective antiretroviral therapy. Zangerle R, Kurz K, Neurauter G, Kitchen M, Sarcletti M, Fuchs D, Brain Behav Immun 2010 24 403 408 10.1016/j.bbi.2009.11.004 19925861
45. Serum phenylalanine concentrations in patients with ovarian carcinoma correlate with concentrations of immune activation markers and of isoprostane-8. Neurauter G, Grahmann AV, Klieber M, Zeimet A, Ledochowski M, Sperner-Unterweger B, Fuchs D, Cancer Lett 2008 272 141 147 10.1016/j.canlet. 2008.07.002 18701209
46. Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes. Orešič M, Simell S, Sysi-Aho M, Näntö-Salonen K, Seppänen-Laakso T, Parikka V, Katajamaa M, Hekkala A, Mattila I, Keskinen P, et al. J Exp Med 2008 205 2975 2984 10.1084/jem.20081800 19075291